Crossmark

Emerging roles of KIR2DL4 in cancer immunotherapy

Crossref DOI link: https://doi.org/10.1007/s12282-025-01738-y

Published Online: 2025-06-23

Published Print: 2025-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Li, Weimiao

Zheng, Guoxu https://orcid.org/0000-0002-7548-5028
Zhang, Shuqun
License Information

Text and Data Mining valid from 2025-06-23

Version of Record valid from 2025-06-23
More Information

Article History

Received: 11 January 2025

Accepted: 11 June 2025

First Online: 23 June 2025

Declarations

:

: All the authors declare that they have no conflict of interest.